Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.12 | 2.26 |
NAV | ₹10.37 | ₹169.86 |
Fund Started | 29 Jul 2025 | 13 Oct 2005 |
Fund Size | ₹1393.74 Cr | ₹1420.55 Cr |
Exit Load | Exit load of 0.50%, if redeemed within 90 days. | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | - | 8.92% |
3 Year | - | 18.87% |
5 Year | - | 21.92% |
1 Year
3 Year
5 Year
Equity | 99.93% | 96.69% |
Cash | 0.07% | 3.31% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
BSE Ltd. | 3.64% |
One97 Communications Ltd. | 3.51% |
Fortis Healthcare Ltd. | 3.33% |
Muthoot Finance Ltd. | 3.04% |
Radico Khaitan Ltd. | 3.00% |
GE Vernova T&D India Ltd | 2.90% |
L&T Finance Ltd. | 2.90% |
JK Cement Ltd. | 2.70% |
Eicher Motors Ltd. | 2.68% |
Narayana Hrudayalaya Ltd. | 2.49% |
Name | Assets |
|---|---|
Infosys Ltd. | 8.79% |
Reliance Industries Ltd. | 6.82% |
ICICI Bank Ltd. | 6.53% |
HDFC Bank Ltd. | 5.93% |
NTPC Ltd. | 4.63% |
Larsen & Toubro Ltd. | 4.59% |
Bharti Airtel Ltd. | 3.99% |
Sun Pharmaceutical Industries Ltd. | 3.69% |
Tata Consultancy Services Ltd. | 3.01% |
Dr. Reddy's Laboratories Ltd. | 2.87% |
Name | Abhishek Bisen | Sri Sharma |
Start Date | 20 Nov 2025 | 30 Apr 2021 |
Name
Start Date
Description | The scheme seek to generate long term capital appreciation by investing predominantly in equity and equity related securities selected based on momentum theme, following an in-house model i.e. enhanced earnings factor model. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 29 Jul 2025 | 13 Oct 2005 |
Description
Launch Date